|
Match
|
Document |
Document Title |
|
|
US20090291146 |
PROCESS FOR MANUFACTURING LACTOSE
A process for producing lactose particles comprises combining a predetermined quantity of lactose seed particles to a first aqueous solution comprising a plurality of lactose particles to form a...
|
|
|
US20090285905 |
SYSTEMS AND PROCESSES FOR SPRAY DRYING HYDROPHOBIC DRUGS WITH HYDROPHILIC EXCIPIENTS
Methods for preparing dry powders having hydrophobic and hydrophilic components comprise combining solutions of the components and spray drying them simultaneously in a spray dryer. The hydrophilic...
|
|
|
US20090285897 |
REHYDRATABLE THIOLATED POLYSACCHARIDE PARTICLES AND SPONGE
Tissue and other body structures may be protected using a hydrated composition made from free-flowing rehydratable particles or a rehydratable sponge comprising substantially collagen-free...
|
|
|
US20090280188 |
ASYMMETRIC FUNCTIONALIZATED NANOPARTICLES AND METHODS OF USE
Disclosed herein are asymmetrically functionalized nanoparticles. Further disclosed herein are methods of preparing asymmetrically functionalized nanoparticles. Asymmetrically functionalized...
|
|
|
US20090280187 |
Oxidation-Stable Granulate Containing Unsaturated Fatty Acids
One aspect of the invention relates to a water-dispersible granulate having a mass weighted average diameter of at least 100 m, said granulate comprising: 40-90 wt. % of carbohydrates; 2-30 wt. %...
|
|
|
US20090280181 |
DELIVERY OF NUCLEIC ACID COMPLEXES FROM PARTICLES
Embodiments of the invention include particles with nucleic acid complexes, medical devices including the same and related methods. In an embodiment, the invention can include a method of making a...
|
|
|
US20090274767 |
PLANT PROTECTION GRANULATES TO BE APPLIED TO LEAF SURFACE
The present invention relates to granules for application to the leaf surface, and to a process for their preparation. The invention furthermore relates to the use of these granules for foliar...
|
|
|
US20090269413 |
FLOWABLE COLLAGEN MATERIAL FOR DURAL CLOSURE
Flowable graft materials are provided which comprise collagen powder and a liquid in an amount sufficient to impart a flowable consistency to the material. The graft materials are sufficiently...
|
|
|
US20090263483 |
NANOPARTICLE FORMULATIONS AND USES THEREOF
The present invention provides compositions comprising nanoparticles comprising: 1) a drug, such as a hydrophobic drug derivative; and 2) a carrier protein. Also provided are methods of treating...
|
|
|
US20090258079 |
Biocompatible Block Copolymer, Use Thereof and Manufacturing Method Thereof
A biocompatible block copolymer having a hydrophobic segment composed of amino acid and hydroxycarboxylic acid and a hydrophilic segment composed of polyalkylene oxide, wherein the terminal not...
|
|
|
US20090257950 |
Membrane Scaffold Proteins
The membrane scaffold proteins (MSP) of the present invention assemble with hydrophobic or partially hydrophobic proteins to form soluble nanoscale particles which preserve native structure and...
|
|
|
US20090252810 |
Aryl/alkyl Succinic Anhydride-Hyaluronan Derivatives
The present invention relates to the modification of hyaluronic acid (HA) with aryl/alkyl succinic anhydrides (ASA) to produce aryl/alkyl succinic anhydride HA derivatives, to the derivatives as...
|
|
|
US20090252803 |
GLYCYRRHETINIC ACID-MEDIATED NANOPARTICLES OF HEPATIC TARGETED DRUG DELIVERY SYSTEM, PROCESS FOR PREPARING THE SAME AND USE THEREOF
Disclosed are a hepatic targeted drug delivery system and a process for preparing the same. Also disclosed is a method for treating liver cancer.
|
|
|
US20090246288 |
Taste-masking oral dosage form and method of preparing the same
The present invention provides a taste-masking oral dosage form which comprises a taste-masked microparticle and an excipient. The taste-masked microparticle comprises a taste-masked crystal...
|
|
|
US20090246287 |
ANTI-ALLERGY COMPOSITIONS
The present invention relates to particles of glucans, particularly oxidized cellulosed for use in medicine. The invention further discloses pharmaceutical compositions for the treatment and/or...
|
|
|
US20090232898 |
Pharmaceutical Compositions Useful in the Treatment of Migraine
There is provided pharmaceutical compositions for the treatment of migraine comprising a pharmacologically-effective amount of a triptan or an ergot, or a pharmaceutically-acceptable salt thereof;...
|
|
|
US20090214666 |
CHITIN MICROPARTICLES AND THEIR MEDICAL USES
The present invention relates to chitin microparticles and their medical uses, in particular in the treatment of allergy, or the treatment of conditions that would benefit from an upregulation of...
|
|
|
US20090208585 |
STABILISATION OF BIOLOGICAL MATERIALS
Biological materials such as vaccines can be stabilised in certain glassy materials, soluble in water. It has been proposed to form these glassy materials as a powder suspended in a non-aqueous...
|
|
|
US20090208584 |
Solid preparation
The solid preparation of the present invention aims at providing a solid preparation superior in the stability during production and preservation even when a poorly water-soluble substance having a...
|
|
|
US20090202642 |
Drug Delivery System Comprising Microparticles and Gelation System
Disclosed are drug delivery compositions comprising a continuous aqueous phase comprising a reverse thermal gelation system comprising a blend of a cellulose derivative and polyethylene glycol; a...
|
|
|
US20090191277 |
PROTEIN NANOPARTICLES
It is an object of the present invention to provide a highly safe composition comprising minoxidil and having high transparency due to the small particle size and high permeability into scalp and...
|
|
|
US20090191276 |
COLLOIDOSOMES HAVING TUNABLE PROPERTIES AND METHODS FOR MAKING COLLOIDOSOMES HAVING TUNABLE PROPERTIES
Colloidosomes having tunable properties, methods for making the same, and applications thereof are described. Colloidosomes described herein are responsive to certain external stimulus to alter one...
|
|
|
US20090181101 |
NANOPARTICLES COMPRISING ANTIBACTERIAL LIGANDS
Materials and Methods are disclosed for producing nanoparticles linked to antibacterial ligands, including antibiotics and/or molecules which bind to bacterial markers, and for the use of the...
|
|
|
US20090180950 |
Polychromatic, diversely-sized particles for angiography
The invention involves polychromatic particles of various sizes for assessing blood flow, blood barrier leakage and blood vessel leakage.
|
|
|
US20090175926 |
TOPICAL BURN TREATMENT
In some embodiments, a method of reducing the possibility of infection in a burn may include one or more of the following steps: (a) identifying a burn wound, (b) applying topically a molecular...
|
|
|
US20090169640 |
COMPOSITONS FOR NASAL ADMINISTRATION OF PHARMACEUTICALS
Compositions for nasal administration, which comprise a pharmaceutical, a physiologically active peptide, or a peptide-related compound, and as the carrier thereof, crystalline cellulose with a...
|
|
|
US20090169639 |
PARTICLES FOR INJECTION AND PROCESSES FOR FORMING THE SAME
In accordance with one aspect of the invention, injectable particles are provided which comprise (a) a vinyl formal polymer, (b) a glucosamine polymer, and (c) an ionically or covalently bound...
|
|
|
US20090169637 |
NANOCOMPOSITE PARTICLES
Nanocomposite particles having good solubility and redispersibility in water are provided. The nanocomposite particles include a sugar material and nanoparticles containing a drug to be delivered...
|
|
|
US20090169636 |
Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
Immunogenic compositions are described herein which comprise microparticles that further comprise a biodegradable polymer. The microparticle compositions also comprise a cationic polysaccharide and...
|
|
|
US20090162407 |
PROCESS FOR PREPARING MICROPARTICLES HAVING A LOW RESIDUAL SOLVENT VOLUME
The disclosed processes for forming microparticles utilize low volumes of processing water while still providing microparticles having low residual solvent levels. The processes are adaptable to...
|
|
|
US20090155373 |
COSMETIC COMPOSITIONS AND METHOD WHICH IMPART A HEALTHY APPEARANCE TO SKIN
A cosmetic product and method of imparting a healthy appearance to skin is provided which includes using a composition formed with about 0.1 to about 20% by weight of the composition of beads, from...
|
|
|
US20090155351 |
Solid Vaccine Formulation
The invention relates to a solid vaccine formulation adapted for mucosal administration comprising at least one antigen as active substance, wherein the formulation comprises a lyophilisate of a...
|
|
|
US20090148535 |
METHOD FOR TREATING CANCER USING INTERFERENCE RNA
The present application discloses acolloidal nanoparticle that includes a therapeutic nucleic acid species and a targeting protein species attached via a coating on the nanoparticle that...
|
|
|
US20090148534 |
Process for producing water-soluble hyaluronic acid modification
The present invention provides a water-soluble modified HA practically used as a drug carrier and a production method thereof. The present invention provides: a water-soluble modified hyaluronic...
|
|
|
US20090148487 |
MOLDABLE BIOMATERIAL FOR BONE REGENERATION
The present invention is directed to a moldable biomaterial comprising a particulate solid porous material and a biodegradable paste material. The paste material and the particulate solid porous...
|
|
|
US20090136584 |
TOOTHPASTE
A toothpaste filled in a container which has two chambers and is capable of simultaneously discharging two different compositions filled respectively in the two chambers when the main body of the...
|
|
|
US20090136569 |
Rapidly disintergrating tablet in oral cavity
The present invention provides a method of suppressing the bitter taste of a drug when a rapidly disintegrating tablet in an oral cavity is produced. When a rapidly disintegrating tablet in an...
|
|
|
US20090130198 |
PHARMACEUTICAL COMPOSITION WITH ENHANCED BIOAVAILABILITY
The invention pertains to a self-emulsifying pharmaceutical composition containing a lipophilic drug, a surfactant, and a hydrophilic carrier. The invention also provides a method for making the...
|
|
|
US20090130184 |
COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING POSTOPERATIVE ILEUS AND GASTRIC STASIS
Disclosed are compositions and methods for preventing or reducing postoperative ileus and gastric stasis. Such compositions comprise a combination of an oxidized regenerated cellulose component and...
|
|
|
US20090123540 |
Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof
A particulate SAE-CD composition is provided. The SAE-CD composition has an advantageous combination of physical properties not found in known solid forms of SAECD. In particular, the SAE-CD...
|
|
|
US20090117195 |
Hydrophilic Particles Based on Cationic Chitosan Derivatives
The present invention provides new nanoparticles and microparticles of hydrophilic character, prepared out of a cationic chitosan derivative and a polyanionic polymer.
|
|
|
US20090110743 |
Porous beta-tricalcium phosphate granules and methods for producing same
A porous β-tricalcium phosphate material for bone implantation is provided. The multiple pores in the porous TCP body are separate discrete voids and are not interconnected. The pore size diameter...
|
|
|
US20090110742 |
Long-acting colloidal insulin formulation and its preparation
The invention relates to injectable long-acting insulin formulations for the treatment of types I and II diabetes in humans and animals. The essential object of the invention is to provide an...
|
|
|
US20090110741 |
METHOD AND COMPOSITIONS FOR POLYMER NANOCARRIERS CONTAINING THERAPEUTIC MOLECULES
A method of controlling a physical characteristic of polymeric nanocarrier-encapsulated protein particles includes altering or selecting a weight percentage of a hydrophobic polymer block in a...
|
|
|
US20090098211 |
SOLID DOSAGE FORMS
Pharmaceutical dosage forms comprising tadalafil are described. Preferred dosage forms are bioequivalent to Cialis® notwithstanding a large particle size.
|
|
|
US20090092674 |
FLOWABLE WOUND MATRIX AND ITS PREPARATION AND USE
This invention relates to a flowable collagen/glycosaminoglycan (GAG) material including particles of collagen/GAG matrix that, when hydrated, can be effectively delivered to wounds having varying...
|
|
|
US20090092660 |
Methods and compositions for needleless delivery of particles
Methods and compositions for needleless delivery of particles to the bloodstream of a subject are provided herein. In one aspect, the invention provides a delivery construct, comprising a receptor...
|
|
|
US20090087494 |
Methods and Compositions for Targeted Delivery of Therapeutic Agents
Compositions and methods for targeted delivery of therapeutic agents, and particularly for mucosal, oral, nasal, or parenteral delivery of therapeutic agents. The compositions comprise carrier...
|
|
|
US20090081308 |
ANHDYROUS LACTOSE AGGLOMERATES AND THE PREPARATION THEREOF
The invention relates to a process for the preparation of anhydrous lactose agglomerates, said process comprising (i) subjecting essentially anhydrous lactose primary particles comprising at least...
|
|
|
US20090068278 |
USE OF FREE RADICAL SCAVENGERS FOR PROTECTING AND TREATING SKIN AND HAIR DAMAGES CAUSED BY CHEMOTHERAPY
The present invention relates to the use of one or more free radical scavengers as prophylactically or therapeutically effective substances and microparticles having an average particle size...
|